You can buy or sell Masimo and other stocks, options, ETFs, and crypto commission-free!
Masimo Corporation Common Stock, also called Masimo, is a medical technology company, which develops, manufactures and markets non invasive patient monitoring technologies, medical devices and sensors. Its products include continuous monitors, patient-worn monitors, hospital automation connectivity, capnography & gas, data download & analytics and sensors & accessories. Read More The company was founded by Joe E. Kiani in May 1989 and is headquartered in Irvine, CA.
52 Week High
52 Week Low
Oil and Gas
Yahoo FinanceMay 22
Here's Why You Should Buy Masimo Stock Right Now
Masimo Corporation MASI has been gaining investor confidence on continued positive results. Over the past year, the stock has rallied 41.9% against the industry’s 3.3% decline. Also, the company has outperformed the S&P 500’s 3.6% rise. The company has an encouraging earnings surprise history, having outpaced the Zacks Consensus Estimate in each of the trailing four quarters, the average being 6.6%. Notably, the consecutive beats underline its operating efficiency. A solid view for 2019 and a slew of devel...
Yahoo FinanceMay 21
Masimo Gets FDA Nod for Radius PPG, Boosts Patient Monitoring
Masimo Corporation MASI recently announced that it has received a 510(k) clearance from the FDA for Radius PPG. This FDA nod will prove beneficial for the company as Radius PPG utilizes the power of clinically proven Masimo SET technology that will deliver accurate measurement while the patients are on the move.
Seeking AlphaMay 20
Masimo's SpHb device effective in noninvasive hemoglobin monitoring
Masimo (NASDAQ:MASI) reports the results of a study in Beijing evaluating the ability Masimo SpHb (noninvasive hemoglobin) to estimate when to conduct invasive hemoglobin measurement to detect possible anemia in patients undergoing spine or cytoreductive surgery.
Expected Jul 31, After Hours